Cited by 1,287Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanismsinterferon and immune responses

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

RETRACTED ARTICLE: Parkin and PINK1 mitigate STING-induced inflammation

Open access

Abstract

Although serum from patients with Parkinson's disease contains elevated levels of numerous pro-inflammatory cytokines including IL-6, TNF, IL-1β, and IFNγ, whether inflammation contributes to or is a consequence of neuronal loss remains unknown 1. Mutations in parkin, an E3 ubiquitin ligase, and PINK1, a ubiquitin kinase, cause early onset Parkinson's disease 2,3. Both PINK1 and parkin function within the same biochemical pathway and remove damaged mitochondria from cells in culture and in animal models via mitophagy, a selective form of autophagy 4. The in vivo role of mitophagy, however, is unclear, partly because mice that lack either PINK1 or parkin have no substantial Parkinson's-disease-relevant phenotypes 5-7. Mitochondrial stress can lead to the release of damage-associated molecular patterns (DAMPs) that can activate innate immunity 8-12, suggesting that mitophagy may mitigate inflammation. Here we report a strong inflammatory phenotype in both Prkn-/- and Pink1-/- mice following exhaustive exercise and in Prkn-/-;mutator mice, which accumulate mutations in mitochondrial DNA (mtDNA)13,14. Inflammation resulting from either exhaustive exercise or mtDNA mutation is completely rescued by concurrent loss of STING, a central regulator of the type I interferon response to cytosolic DNA 15,16. The loss of dopaminergic neurons from the substantia nigra pars compacta and the motor defect observed in aged Prkn-/-;mutator mice are also rescued by loss of STING, suggesting that inflammation facilitates this phenotype. Humans with mono- and biallelic PRKN mutations also display elevated cytokines. These results support a role for PINK1- and parkin-mediated mitophagy in restraining innate immunity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-018-0448-9This paper is marked retracted.

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Cited by

Sorted by citations

Items 301–400 of 1,001

Metadata

Authors
Sliter, D. A., Martinez, J., Hao, L., Chen, X., Sun, N., Fischer, T. D., Burman, J. L., Li, Y., Zhang, Z., Narendra, D. P., Cai, H., Borsche, M., Klein, C., & Youle, R. J.
Affiliations
  • National Institutes of Health (US)
  • University of Lübeck (DE)
Corresponding author
Youle, Richard J.
Venue
Nature
Published
2018-08-22
Volume
561
Issue
7722
Pages
258-262
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2887997888
Cited by
1,287
References
39
Citations by year
2026: 68 · 2025: 177 · 2024: 190 · 2023: 185 · 2022: 180 · 2021: 197 · 2020: 157 · 2019: 115 · 2018: 16
FWCI
82.18
Type
journal article
Language
en
Status
Retracted
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
  • National Institutes of Health
  • National Institute on Alcohol Abuse and Alcoholism (DFG FOR2488)
  • National Institute of Neurological Disorders and Stroke (Z01NS002859, ZIANS002859)
  • National Institute of Environmental Health Sciences (1ZIAES10328601, ZIAES103286)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
Keywords
Parkin, PINK1, STING, mitophagy, Parkinson's disease, neuroinflammation, mitochondrial DNA mutations, exhaustive exercise, innate immunity, dopaminergic neurons, substantia nigra pars compacta, motor impairment, type I interferon response, cytosolic DNA, E3 ubiquitin ligase
MeSH terms
Alarmins, STING Protein, PTEN-Induced Putative Kinase, Animals, DNA, Mitochondrial, Humans, Immunity, Innate, Inflammation, Membrane Proteins, Mice, Inbred C57BL, Parkinson Disease, Physical Conditioning, Animal, Protein Kinases, Stress, Physiological, Ubiquitin-Protein Ligases, Mice, Receptor, Interferon alpha-beta, Mitophagy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review